探索乙氨基前期药物和混合物:一项审查
1Laboratorio de Química Orgánica y Biomolecular, Escuela de Química, Universidad Industrial de Santander Cl. 9 # Cra 27 A.A. 680006 Bucaramanga Colombia kouznet@uis.edu.co vkuznechnik@gmail.com.
RSC advances
|March 25, 2024
概括
这篇评论探讨了新的乙氨基 (APAP) 和NSAID分子组合,如前期药物和混合物,以创造更安全,更有效的止痛药物. 一个新的分类有助于研究先进的止痛药设计.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 乙氨基 (APAP) 和NSAID是常见的止痛药,但有不良影响.
- 开发具有改进性质的创新药物对于疼痛管理至关重要.
- 结合现有药物提供了一种切实可行的方法来减轻副作用.
研究的目的:
- 审查开发用于治疗疼痛综合征的新分子的进展.
- 探索APAP的分子组合,包括前期药物,代药物和混合物.
- 为这些基于APAP的实体提出一个新的结构分类.
主要方法:
- 对APAP和NSAID组合的现有文献进行批判性审查.
- 结构分析和分类APAP前药物,三种药物和混合物.
- 对NSAID-APAP分子,C结合的APAP和NO释放混合物的和胺的检查.
主要成果:
- 一个拟议的分类包括载体链接的O-修饰的APAP,N-链接的修饰APAP衍生物 (前药物) 和直接和间隔N,O-链接的APAP杂交物 (codrugs).
- 具体的例子,如甲,甲酸,乙氨醇,甲,和代理JNJ-10450232符合这一分类.
- 该分类有助于理解用于新型止痛药的结构-活性关系 (SAR) 研究.
结论:
- 拟议的分类为分析APAP和NSAID分子组合提供了一个新的框架.
- 这种分类促进了基于APAP和NSAIDs的新止痛药的研究和设计.
- 分子组合的进步提供了更好的药物特性和潜在的更安全的疼痛管理选择.
相关概念视频
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Phase II Reactions: Acetylation Reactions
223
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
223
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
199
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
199
Phase II Reactions: Glucuronidation
410
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
410
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K


